CALL/PFIZER INC/45/0.1/20.09.24 Stock

Warrant

DE000GQ4LTV8

Real-time BOERSE MUENCHEN 08:25:26 2024-06-27 EDT
0.002 EUR 0.00% Intraday chart for CALL/PFIZER INC/45/0.1/20.09.24
Current month-33.33%
1 month-50.00%
Date Price Change
24-06-27 0.002 0.00%
24-06-26 0.002 -33.33%
24-06-25 0.003 0.00%
24-06-24 0.003 0.00%
24-06-21 0.003 0.00%

Real-time BOERSE MUENCHEN

Last update June 27, 2024 at 08:25 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Goldman Sachs
WKN GQ4LTV
ISINDE000GQ4LTV8
Date issued 2023-09-07
Strike 45 $
Maturity 2024-09-20 (85 Days)
Parity 10 : 1
Emission price 0.06
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.06
Lowest since issue 0.002
Delta0.05x
Omega 9.731
Premium64.58x
Gearing213.15x
Moneyness 0.6093
Difference Strike 17.58 $
Difference Strike %+39.07%
Spread 0.02
Spread %90.91%
Theoretical value 0.0120
Implied Volatility 56.71 %
Total Loss Probability 97.49 %
Intrinsic value 0.000000
Present value 0.0120
Break even 45.13 €
Theta-0x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.42 USD
Average target price
31.92 USD
Spread / Average Target
+16.39%
Consensus